Q-omics provides the consensus-scored LINC02128 profile across patient tissues and cancer cell-line models. LINC02128 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02128 is differentially expressed in 12, with the highest sampling consensus in KICH. Additionally, LINC02128 RNA expression shows 8,608 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KICH, and GBM as cancer lineages where LINC02128 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02128 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02128 survival associations across molecular data types. LINC02128 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02128 RNA expression–survival associations across cancer types. High LINC02128 expression shows unfavorable associations in KICH, COAD, ACC and BRCA, but favorable associations in UCEC and KIRP. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02128 RNA expression.
This table summarizes LINC02128 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02128. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02128 shows lower tumor expression in KICH and KIRP and higher tumor expression in HNSC, COAD, UCEC and STAD. The KICH box plot shows higher LINC02128 RNA expression in normal versus tumor tissue (log2 FC = −1.101, t-test p < 0.001).
This table shows molecular features associated with LINC02128 in patient tissues and cancer cell lines. In patient samples, LINC02128 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
